TROY, Mich. – When medical devices like dialysis machines or respiratory devices break down, medical companies typically need to send a technician for on-site repair. These service calls typically cost $1,000 or more each time.

Delphi Medical Systems, a subsidiary of Delphi Corp., has created a revolutionary "virtual technician" system that will enable medical companies to diagnose and repair these devices remotely through a secure website. This new customized service, unique to the medical industry, will greatly reduce the number of on-site service calls and provide faster help to the end consumer. The diagnostic feedback can also identify hardware problems, generate service calls, and automatically ship spare parts to OEM technicians in the field using Delphi Medical Systems' order fulfillment system.

"This is yet another example of technology improving business practices within the healthcare industry," said Christophe Sevrain, managing director of Delphi Medical Systems. "This 'virtual technician' service now provides OEMs a constant diagnostic tool, in addition to having the ability to significantly reduce service calls." The "virtual technician" system is a customized monitoring service, based on Delphi Medical Systems' existing remote monitoring infrastructure that will allow medical companies to optimize the performance of their equipment. They can use this single system to access all of their machines in operation.

The new system will monitor dialysis machines, vital sign monitors, respiratory care devices and infusion pumps.

OEMs can use their Windows-based PC or PDA to access their machine's information transmitted through Delphi Medical Systems' secure website. If the data transmitted indicates the need for software upgrades or a system reboot, the action can be performed remotely through the system. The "virtual technician"' service, once customized for a particular OEM, will continually monitor all of that OEM's machines – including checking on the machine's battery life, sensors output and recorded events.

Another service offered by the Delphi Medical Systems repair center is setting up a loaner machine for patient use while theirs is being repaired.

Beyond remote diagnostics, the service can also monitor a machine's disposable supply – even being set up to automatically re-stock disposable supply items, such as infusion sets and glucose strips, using Delphi Medical Systems' order fulfillment system.

This service entails a one-time start-up fee for the system's customization between the OEM's equipment and Delphi Medical Systems' system. The flat monthly fees will vary depending on the number of machines in the system and amount of information being provided for each connected machine. OEMs can start using the "virtual technician" service as soon as the system is customized to their specifications.

About Delphi Medical Systems
Delphi Medical Systems is a world-class provider of technology, products and product development and manufacturing for respiratory care, IV infusion, vital signs monitoring, dialysis equipment, in-vitro diagnostics and surgical / hospital equipment. Its capabilities stem from Delphi's vast technology base, product development expertise and manufacturing excellence.

For more information on Delphi Medical Systems, please visit www.delphimedical.com.

FORWARD LOOKING STATEMENT
All statements contained or incorporated in this press release which address operating performance, events or developments that we expect or anticipate may occur in the future (including statements relating to future sales or earnings expectations, volume growth, awarded sales contracts or statements expressing general optimism about future operating results) are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are made on the basis of management's current views and assumptions with respect to future events. Important factors, risks and uncertainties which may cause actual results to differ from those expressed in our forward-looking statements are discussed in detail in our filings with the Securities and Exchange Commission, including our annual report on Form 10-K for the year ended December 31, 2003. In particular, the achievement of projected levels of royalties and profit margins over a licensing agreement will depend in part on customer demand which may be affected by, among other things, uncertainty of product development and manufacturing, uncertainty about obtaining and maintaining FDA regulatory clearances and the timing of receiving marketing clearances, uncertainty relating to third party reimbursement, ability to convince health care professionals and third party payers of the medical and economic benefits of the licensed products, changes in general economic conditions, and changes in our ability to satisfy service, technology, quality and other requirements. Delphi does not intend or assume any obligation to update any of these forward-looking statements.